Get 20% lifetime commission for referring investors to digrin.com
here.
Monte Rosa Therapeutics, Inc. ( GLUE) - Stock Earnings
Stock symbol GLUE is outdated, potentially delisted? Maybe it is available on other exchange?
GLUE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
GLUE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -26.5 million USD | 0 USD |
| 2022Q3 | -27.3 million USD | 0 USD |
| 2022Q4 | -30.8 million USD | 0 USD |
GLUE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -35.9 million USD | 0 USD |
| 2021 | -74.0 million USD | 0 USD |
| 2022 | -108.5 million USD | 0 USD |
GLUE
Price: $5.65
52 week price:
Earnings Per Share: -2.69 USD
P/E Ratio: -1.61
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 41268
Market Capitalization: 216.9 million